Regulatory filing for house dust mite allergy tablet

ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced that its Biologics License Application (BLA) for its house dust mite (HDM) sublingual allergy...

Canada's Preeminent Industrial Filter Products Solution

Vytal Filtration Technologies announces an expansion into the United States market with the opening of a sales office in California....

Parex Resources Announces 12 Consecutive Years of Reserves

CALGARY, Alberta, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Parex Resources Inc. (“Parex” or the “Company”) (TSX: PXT) is pleased to announce the results of its...

Evs Full Year 2022 Results to be Announced on Friday 17

Publication on February 2, 2023.EVS Broadcast Equipment S.A.: Euronext Brussels (EVS.BR), Bloomberg (EVS BB), Reuters (EVSB.BR) EVS FULL YEAR 2022...

OFL stands in support of new NDP leader Marit Stiles

TORONTO, Feb. 02, 2023 (GLOBE NEWSWIRE) -- The Ontario Federation of Labour (OFL) stands in support of new Ontario NDP leader Marit Stiles. The OFL’s...

B2B Payments Company SendFriend Acquires Compliance

[img]https://ml.globenewswire.com/Resource/Download/5a6185b2-a075-4622-bd6a-0a24a47b5473?size=1[/img]New York, Feb. 02, 2023 (GLOBE NEWSWIRE) -- B2B Payments Company SendFriend Acquires Compliance Provider DigiPli

HPU Students Learn from Apple Co-Founder Steve Wozniak

HIGH POINT, N.C., Feb. 02, 2023 (GLOBE NEWSWIRE) -- High Point University welcomed Apple Co-Founder Steve Wozniak, HPU’s Innovator in Residence, back to...

Revolution Medicines to Participate in Upcoming Investor

REDWOOD CITY, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted...

Brunswick Corporation Releases Fourth Quarter and Full Year

METTAWA, Ill., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Brunswick Corporation (NYSE: BC), today, released its fourth quarter and fully year 2022 financial...

ORIC Pharmaceuticals to Participate in Upcoming Investor

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company...